191 |
Hepatic Lrp1 deficiency and the development of nonalcoholic fatty liver diseaseHamlin, Allyson January 2017 (has links)
No description available.
|
192 |
Induction of the Lipid Regulator PPAR-Delta in FoxO1 Overexpressed Skeletal MuscleMarkovic, Vesna 14 December 2018 (has links)
No description available.
|
193 |
Phospholipids and Glycolipids of the Oral Bacterium <i>Streptococcus mutans</i> UA159Custer, Jenny Elise 04 August 2011 (has links)
No description available.
|
194 |
The influence of lipid content and lipoxygenase on flavor volatiles in the tomato peel and fleshTies, Paige 19 June 2012 (has links)
No description available.
|
195 |
Maternal and infant essential fatty acids status in Havana, CubaKraševec, Julia Maria. January 1999 (has links)
No description available.
|
196 |
Yogurt as a Vehicle for Omega-3 Fatty Acid EnrichmentRognlien, Marnie 19 May 2010 (has links)
Consumer interest in supplementation with healthy omega-3 fatty acids (Ï 3 FA) has led to increased research in fortification of popular foods with these healthy fats. Yogurt, which is already popular, offers a functional food matrix to fortify with Ï 3 FA. Fish oil, a major source of two important long chain Ï 3 FA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is an excellent source of Ï 3 FA enrichment into foods but brings problems of oxidation and off-flavors or odors when added to foods. Encapsulation, deodorized fish oil, and flavoring have been investigated to reduce these off-flavors and odors in food products while producing a fish oil-fortified yogurt.
Discrimination of butter, fish or oxidized fish oil at 0.5% (wt/wt) levels was investigated in unflavored low-fat (1%) yogurt using untrained panelists (n=31) and sensory triangle tests. Five sensory attributes (lime, sweet, heat, acid, oxidized) were analyzed by experienced sensory panelists (n=12) in chile-lime flavored yogurts with butter, fish or oxidized fish oils added at low (0.43%) and high (1% wt/wt) levels. Analytical analysis for composition, fatty acid profile, and volatile chemistry of the yogurts was conducted. Consumer acceptance of a low-fat (1.5%) chile-lime flavored yogurt enriched with fish oil was investigated using a 9-point hedonic scale (1="dislike extremely", 9="like extremely").
Untrained panelists (n=31) were unable to differentiate 0.5% (wt/wt) levels of fish and butter oils in unflavored yogurts but were able to detect oxidized fish oil compared to butter or fish oil under in the same conditions. Experienced panelists (n=12) found significant differences (p<0.05) in lime and acid attributes in chile-lime flavored yogurts containing 1% (wt/wt) oxidized fish oil compared with 0.43 and 1% (wt/wt) butter and fish oil yogurts and 0.43% (wt/wt) oxidized fish oil yogurts. Oxidized attributes were determined as significantly different (p<0.05) by experienced panelists in chile-lime yogurts with 1% (wt/wt) fish oil, 0.43 and 1% (wt/wt) oxidized fish oil added. The acceptance of a fish oil-enriched chile-lime flavored yogurt was neutral ("neither liked nor disliked") by consumers (n=100) but 44% rated the product "like slightly" (6 of 9) or greater. A successful chile-lime flavored yogurt offering a novel savory flavor was formulated from pre-pasteurization addition of fish oil to deliver more than 145 mg DHA+EPA/170 g serving of yogurt. / Master of Science
|
197 |
Characterization of a glycerophosphodiester phosphodiesterase in the human malaria parasite Plasmodium falciparumDenloye, Titilola Ifeoma 08 June 2012 (has links)
Active lipid metabolism is a key process required for the intra-erythrocytic development of the malaria parasite, Plasmodium falciparum. Enzymes that hydrolyze host-derived lipids play key roles in parasite growth, virulence, differentiation, cell-signaling and hemozoin formation. Therefore, investigating enzymes involved in lipid degradation could uncover novel drug targets. We have identified in P. falciparum, a glycerophosphodiester phosphodiesterase (PfGDPD), involved in the downstream pathway of phosphatidylcholine degradation. PfGDPD hydrolyzes deacylated phospholipids, glycerophosphodiesters to glycerol-3-phosphate and choline. In this study, we have characterized PfGDPD using bioinformatics, biochemical and genetic approaches. Knockout experiments showed a requirement for PfGDPD for parasite survival. Sequence analysis revealed PfGDPD possesses the unique GDPD insertion domain sharing a cluster of conserved residues present in other GDPD homologues. We generated yellow fluorescent fusion proteins that revealed a complex distribution of PfGDPD within the parasite cytosol, parasitophorous vacuole and food vacuole. To gain insight into the role of PfGDPD, sub-cellular localization was modulated and resulted in a shift in protein distribution, which elicited no growth phenotype. Kinetic analyses suggest PfGDPD activity is Mg₂⁺ dependent and catalytically efficient at the neutral pH environment of the parasitophorous vacuole. Next, our aim was to determine the upstream pathway that provides deacylated glycerophosphodiesters as substrate for PfGDPD. We identified via bioinformatics, a P. falciparum lysophospholipase (PfLPL1) that directly generates the substrate. Knockout clones were generated and genotyped by Southern and PCR analysis. The effects of PfLPL1 knockouts on parasite fitness were studied, and the results showed that PfLPL1was not required for parasite survival and proliferation. / Ph. D.
|
198 |
Controlling Light Oxidation Flavor in Omega-3 Fatty Acid Enriched 2% Milk by Packaging FilmsLi, Qin 05 July 2011 (has links)
Milk is often packaged in translucent containers providing little protection against flavor degradation from light. Addition of omega-3 fatty acid sources into milk increases the risk of light-initiated degradation of nutrients and sensory quality.
The effectiveness of iridescent film materials in reducing light-induced oxidation of extended shelf-life omega-3 fatty acid enriched milk (2% total fat) was studied. Film selections were targeted to provide product visibility and control product exposure at targeted riboflavin excitation wavelength regions. Effectiveness was determined by sensory evaluation and measuring changes in volatile compounds on days 1, 7, 14, and 21 when stored under fluorescent light at 4°C. Five packaging treatments (films overwrapped on glass bottles) were evaluated: 446nm block, 570 nm block, broad spectrum block with 4% transmission (BS4T), light-protected (foil overwrap) control, and light-exposed (no overwrap) control. Experienced panelists (n=12) rated oxidized flavor intensity (0-9; 9=extreme) for milk samples. Light-protected milk was lower in oxidized flavor (mean score less than 3) throughout the storage period. Oxidized flavor in milk with BS4T film overwraps was not different compared to light-protected milk (p>.05) at the later stage (21 days), suggesting some level of protection to milk flavor. Milk without fish oil (milk fat only) shows relatively larger peak areas for 2-butanone on day 14, compared to other milk samples, suggesting antioxidants in the fish oil can prevent light oxidation. Overall, packaging that provides a complete light block is still the best way to prevent light-oxidized flavor in milk. / Master of Science in Life Sciences
|
199 |
Analysis of volatile compounds, proximate composition, and fatty acids in Pacific bluefin tuna (Thunnus orientalis)James, Cierra Alisha 07 June 2022 (has links)
Pacific bluefin tuna (PBT; Thunnus orientalis) has grown significantly in popularity in recent years due to the globalization of Japanese cuisine. PBT is highly sought after for sushi and sashimi products due to its great quality and taste. Wild populations of this species have been affected by their increasing popularity, pushing innovators in the food industry to create meat alternative versions of PBT. The muscle composition of PBT varies, leading to different types (cuts) of meat in a way that is analogous to various cuts of beef. This study evaluated the differentiation amongst the 6 distinct cuts, including otoro, ventral akami, dorsal akami, ventral chu-toro, dorsal chu-toro, and wakaremi conducting volatile analysis, proximate analysis, and fatty acid analysis. The results from these analyses can then be used as a base standard for companies seeking to create alternatives versions of PBT. Samples analyzed in this study were cultured PBT species that were caught as juveniles and raised in captivity on a PBT farm in Mexico. Volatile analysis was conducted using a SPME GC/MS method. Overall, 41 aroma compounds were identified in PBT that met the identification criteria, including 9 aldehydes, 7 alcohols, 14 alkanes, 2 ketones, 4 alkenes, 3 aromatic compounds, and 2 miscellaneous compounds. Proximate analyses were conducted using standard methods. Significant differences (p <0.05) were found between each cut for the proximate analysis. The fatty acid analysis determined that there were twenty-two identifiable fatty acids found in the different cuts. The omega-3 fatty acids eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) with DHA being present at a higher amount than EPA in each cut. Overall, there are similarities and differences among the different cuts of bluefin tuna that researchers would need to mimic to provide adequate nutritional and sensorial properties of PBT. / Master of Science in Life Sciences / Pacific bluefin tuna (PBT; Thunnus orientalis) is a fish that has gained tremendous popularity over the years due to the globalization of Japanese cuisine. This tuna species is synonymous with high quality and great taste, making it key for sushi and sashimi dishes. The increased demand for this species has caused wild populations to decrease; therefore, the food industry has sought to create meat alternatives for the species. The PBT has 6 distinct cuts that make up the composition of the fish, similar to the differences that can be found in beef cuts. These 6 distinct cuts are otoro, ventral akami, dorsal akami, ventral chu-toro, dorsal chu-toro, and wakaremi. The purpose of this study is to determine the aroma composition, fatty acid composition, and fat, moisture, ash, and protein contents of the different cuts. To measure the aroma composition, gas-chromatography mass spectroscopy (GC-MS) was used; it is a machine that can be used to identify and measure the aroma compounds of products. Standard procedures were used for the other analyses. Overall, 41 aroma compounds were identified in PBT that met the identification criteria, consisting of aldehydes, alcohols, alkanes, ketones, alkenes, aromatic compounds, and some miscellaneous compounds. The cuts displayed distinguishable differences in their fat, ash, moisture, and protein contents. The fatty acid analysis concluded that there were twenty-two identifiable fatty acids found in the different cuts. In this study, close attention was paid to omega-3 fatty acids due to their health benefits for consumers. The omega-3 fatty acids eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) were found in all cuts with DHA being present at a higher amount than EPA in each cut. From this study, researchers have the foundation for understanding the composition of PBT to create a meat alternative that meets consumer expectations.
|
200 |
Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastasesWatson, H., Cockbain, A.J., Spencer, Jade A., Race, Amanda D., Volpato, Milène, Loadman, Paul, Toogood, G.J., Hull, M.A. 07 October 2016 (has links)
Yes / We investigated red blood cell (RBC) PUFA profiles, and the predictive value of RBC EPA content for tumour EPA exposure and clinical outcomes, in the EMT study, a randomised trial of EPA in patients awaiting colorectal cancer (CRC) liver metastasis surgery (A.J. Cockbain et al., 2014). There was a significant increase in RBC EPA in the EPA group (n=43; median intervention 30 days; mean absolute 1.26 [±0.14]% increase; P<0.001), but not in the placebo arm (n=45). EPA incorporation varied widely in EPA users and was not explained by treatment duration or compliance. There was little evidence of ‘contamination’ in the placebo group. The EPA level predicted tumour EPA content (r=0.36; P=0.03). Participants with post-treatment EPA ≥1.22% (n=49) had improved OS compared with EPA <1.22% (n=29; HR 0.42[95%CI 0.16–0.95]). RBC EPA content should be evaluated as a biomarker of tumour exposure and clinical outcomes in future EPA trials in CRC patients.
|
Page generated in 0.0828 seconds